Literature DB >> 10550160

Quality-of-life measurement in advanced cancer: assessing the individual.

D Waldron1, C A O'Boyle, M Kearney, M Moriarty, D Carney.   

Abstract

PURPOSE: Despite the increasing importance of assessing quality of life (QoL) in patients with advanced cancer, relatively little is known about individual patient's perceptions of the issues contributing to their QoL. The Schedule for the Evaluation of Individual Quality of Life (SEIQoL) and the shorter SEIQoL-Direct Weighting (SEIQoL-DW) assess individualized QoL using a semistructured interview technique. Here we report findings from the first administration of the SEIQoL and SEIQoL-DW to patients with advanced incurable cancer. PATIENTS AND METHODS: QoL was assessed on a single occasion using the SEIQoL and SEIQoL-DW in 80 patients with advanced incurable cancer.
RESULTS: All patients were able to complete the SEIQoL-DW, and 78% completed the SEIQoL. Of a possible score of 100, the median QoL global score was as follows: SEIQoL, 61 (range, 24 to 94); SEIQoL-DW, 60.5 (range, 6 to 95). Psychometric data for SEIQoL indicated very high levels of internal consistency (median r =.90) and internal validity (median R(2) = 0.88). Patients' judgments of their QoL were unique to the individual. Family concerns were almost universally rated as more important than health, the difference being significant when measured using the SEIQoL-DW (P =.002).
CONCLUSION: Patients with advanced incurable cancer were very good judges of their QoL, and many patients rated their QoL as good. Judgments were highly individual, with very high levels of consistency and validity. The primacy given to health in many QoL questionnaires may be questioned in this population. The implications of these findings are discussed with regard to clinical assessment and advance directives.

Entities:  

Mesh:

Year:  1999        PMID: 10550160     DOI: 10.1200/JCO.1999.17.11.3603

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  40 in total

1.  Who should measure quality of life?

Authors:  J Addington-Hall; L Kalra
Journal:  BMJ       Date:  2001-06-09

2.  Assessing individual quality of life in amyotrophic lateral sclerosis.

Authors:  S Clarke; A Hickey; C O'Boyle; O Hardiman
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  Feasibility and validity of a computer administered version of SEIQoL-DW.

Authors:  L Ring; A Kettis Lindblad; P Bendtsen; E Viklund; R Jansson; B Glimelius
Journal:  Qual Life Res       Date:  2006-09-13       Impact factor: 4.147

4.  [The need for autonomy in the process of care-conceptual framework and research perspectives].

Authors:  J Behrens; M Zimmermann
Journal:  Z Gerontol Geriatr       Date:  2006-06       Impact factor: 1.281

Review 5.  The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW.

Authors:  L Wettergren; A Kettis-Lindblad; M Sprangers; L Ring
Journal:  Qual Life Res       Date:  2009-06-03       Impact factor: 4.147

Review 6.  Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.

Authors:  Eileen Mannion; J J Gilmartin; Paul Donnellan; Maccon Keane; Dympna Waldron
Journal:  Support Care Cancer       Date:  2014-02-22       Impact factor: 3.603

7.  Measuring individual quality of life in patients receiving radiation therapy: the SEIQoL-Questionnaire.

Authors:  Gerhild Becker; Constanze S Merk; Cornelia Meffert; Felix Momm
Journal:  Qual Life Res       Date:  2014-03-01       Impact factor: 4.147

8.  Relative importance and interrelations between psychosocial factors and individualized quality of life of hemodialysis patients.

Authors:  David Tovbin; Yori Gidron; Tzipora Jean; Ricardo Granovsky; Alla Schnieder
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

9.  Cognitive strategies and quality of life of patients with high-grade glioma.

Authors:  C Lucchiari; A Botturi; A Silvani; E Lamperti; P Gaviani; A Innocenti; C Y Finocchiaro; M Masiero; G Pravettoni
Journal:  Support Care Cancer       Date:  2015-03-12       Impact factor: 3.603

10.  Proxy assessment of quality of life in patients with prostate cancer: how accurate are partners and urologists?

Authors:  R Pearcy; D Waldron; C O'Boyle; R MacDonagh
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.